Literature DB >> 20635566

High blood pressure in the pediatric age group.

Helena Andrade1, Natália Antonio, Dina Rodrigues, Marinho Da Silva, Mariano Pêgo, Luís Augusto Providência.   

Abstract

The definition of hypertension (HT) in the pediatric age group is based on the normal distribution of blood pressure (BP) in healthy children. Normal BP is defined as being below the 90th percentile for gender, age and height, and hypertension as equal to or higher than the 95th percentile on at least three separate occasions. If the values are above the 90th percentile but below the 95th percentile, the child should be considered prehypertensive. Ambulatory BP monitoring is useful in the assessment of BP levels in the young. P values in children and adolescents have creased in the last decade, in parallel with increases in body mass index, and HT now has a prevalence of 2-5%. Obesity in childhood and adolescence is one of the main predictors of HT in adulthood, but it is also associated with other cardiovascular risk factors such as dyslipidemia, abnormal glucose metabolism, insulin resistance, inflammation and impaired vascular function. Left ventricular hypertrophy is the most prominent evidence of target organ damage caused by hypertension in children and adolescents. The goal for antihypertensive treatment is to reduce BP below the 95th percentile. Weight control, with regular physical activity and dietary changes, is the primary therapy for obesity-related hypertension. Weight loss decreases not only BP but also other cardiovascular risk factors. The indications for use of antihypertensive drugs are: symptomatic hypertension, secondary hypertension, established hypertensive target organ damage, stage 2 hypertension and failure of nonpharmacologic measures.

Entities:  

Mesh:

Year:  2010        PMID: 20635566

Source DB:  PubMed          Journal:  Rev Port Cardiol        ISSN: 0870-2551            Impact factor:   1.374


  8 in total

Review 1.  Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors.

Authors:  M R Meyer; D J Clegg; E R Prossnitz; M Barton
Journal:  Acta Physiol (Oxf)       Date:  2011-02-01       Impact factor: 6.311

2.  Noninvasive imaging in children with hypertension.

Authors:  Derek J Roebuck; Clare A McLaren
Journal:  Pediatr Radiol       Date:  2013-03-03

3.  Therapeutic options for the treatment of hypertension in children and adolescents.

Authors:  Mary M Stephens; Beth A Fox; Lisa Maxwell
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2012-02-29

4.  Blood pressure and associated factors in a North African adolescent population. a national cross-sectional study in Tunisia.

Authors:  Hajer Aounallah-Skhiri; Jalila El Ati; Pierre Traissac; Habiba Ben Romdhane; Sabrina Eymard-Duvernay; Francis Delpeuch; Noureddine Achour; Bernard Maire
Journal:  BMC Public Health       Date:  2012-02-03       Impact factor: 3.295

5.  Prevalence of Prehypertension and Hypertension in a Nationally Representative Sample of Iranian Children and Adolescents: The CASPIAN-IV Study.

Authors:  Zahra Fallah; Mostafa Qorbani; Mohammad Esmaeil Motlagh; Ramin Heshmat; Gelayol Ardalan; Roya Kelishadi
Journal:  Int J Prev Med       Date:  2014-03

6.  Intra-uterine growth restriction as a risk factor for hypertension in children six to 10 years old.

Authors:  Agata Zamecznik; Katarzyna Niewiadomska-Jarosik; Agnieszka Wosiak; Justyna Zamojska; Jadwiga Moll; Jerzy Stańczyk
Journal:  Cardiovasc J Afr       Date:  2014 Mar-Apr       Impact factor: 1.167

7.  Major dietary patterns and their associations with overweight and obesity among Iranian children.

Authors:  Maryam Bahreynian; Zamzam Paknahad; Mohammad Reza Maracy
Journal:  Int J Prev Med       Date:  2013-04

8.  Correlation of Insulin Resistance with Anthropometric Measures and Blood Pressure in Adolescents.

Authors:  Polyana Resende Silva de Morais; Ana Luiza Lima Sousa; Thiago de Souza Veiga Jardim; Flávia Miquetichuc Nogueira Nascente; Karla Lorena Mendonça; Thaís Inácio Rolim Povoa; Carolina de Souza Carneiro; Vanessa Roriz Ferreira; Weimar Kunz Sebba Barroso de Souza; Paulo César Brandão Veiga Jardim
Journal:  Arq Bras Cardiol       Date:  2016-03-22       Impact factor: 2.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.